TriNetX Acquires Key Assets of Zetta Genomics to Enhance Genomics Data Capabilities

The acquisition will allow TriNetX to further support research and patient care innovation through Zetta's award-winning XetaBase technology.

Apr. 7, 2026 at 12:37pm

Got story updates? Submit your updates here. ›

A bold, abstract painting in soft blues, greens, and grays, featuring sweeping geometric shapes and precise botanical spirals, conceptually representing the integration of complex genomics data and healthcare research networks.The acquisition of Zetta Genomics' assets will enable TriNetX to further integrate genomics data into its global health research network, driving innovation in personalized medicine.Cambridge Today

TriNetX, a leading health research network, has announced the acquisition of key assets from Zetta Genomics, a company specializing in genomics data management and analytics. The acquisition will enable TriNetX to strengthen its ability to federate and analyze genomics data across its global network of healthcare providers.

Why it matters

The integration of Zetta Genomics' technology and expertise will enhance TriNetX's capacity to support research and patient care innovation by providing more robust and comprehensive genomics data capabilities. This is particularly important as the healthcare industry continues to emphasize the importance of personalized medicine and the integration of genomic information into clinical decision-making.

The details

Through the acquisition, TriNetX will continue to support all existing Zetta Genomics customers and their use of the XetaBase technology platform. The XetaBase platform is an award-winning solution for managing and analyzing genomics data, which will now be integrated into TriNetX's broader health research network.

  • TriNetX announced the acquisition on April 7, 2026.

The players

TriNetX

A leading health research network that connects healthcare organizations, biopharma, and contract research organizations to accelerate clinical research and innovation.

Zetta Genomics

A company specializing in genomics data management and analytics, known for its award-winning XetaBase technology platform.

Steve Kundrot

The Chief Operating Officer of TriNetX, who led the partnership activities with Zetta Genomics.

Got photos? Submit your photos here. ›

The takeaway

The acquisition of Zetta Genomics' assets by TriNetX represents a significant step forward in the healthcare industry's efforts to leverage genomics data to drive research and personalized patient care. By integrating Zetta's expertise and technology, TriNetX is poised to enhance its ability to support innovation and collaboration across its global network of healthcare providers.